TRILLIUM THERAPEUTICS INC. Operating Cash Flow
TRILLIUM THERAPEUTICS INC. reported Operating Cash Flow of -$42.55 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2021-11-12
- TRILLIUM THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2021-09-30 was -$13.99M.
- TRILLIUM THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2021-06-30 was -$11.48M.
- TRILLIUM THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2021-03-31 was -$17.08M.
- TRILLIUM THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2020-12-31 was -$4.92M.
- TRILLIUM THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2020 was -$22.73M.
- TRILLIUM THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2019 was -$24.75M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$13.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$25.47M derived: sum of 2 quarters · filed 2021-11-12 | -$42.55M 10-Q · filed 2021-11-12 | -$47.46M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | -$11.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$28.56M 10-Q · filed 2021-08-13 | -$33.47M derived: sum of 3 quarters · filed 2021-08-13 | -$37.68M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | -$17.08M 10-Q · filed 2021-05-07 | -$21.99M derived: sum of 2 quarters · filed 2021-05-07 | -$26.20M derived: sum of 3 quarters · filed 2021-11-12 | -$32.52M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | -$4.92M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$9.12M derived: sum of 2 quarters · filed 2021-11-12 | -$15.44M derived: sum of 3 quarters · filed 2021-11-12 | -$22.73M 10-K · filed 2021-03-18 |
| 2020-09-30 | -$4.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$10.53M derived: sum of 2 quarters · filed 2021-11-12 | -$17.82M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$6.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$13.61M 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$7.29M 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | -$24.75M 10-K · filed 2021-03-18 |